Search results
This report presents voting results for the subset of questions pertaining to intermediate- and high-risk and locally advanced prostate cancer, biochemical relapse after definitive treatment, advanced (next-generation) imaging, and management of side effects caused by hormonal therapies.
- Management of Patients with Advanced Prostate Cancer. Report from the ...
The 2024 Advanced Prostate Cancer Consensus Conference...
- Management of Patients with Advanced Prostate Cancer. Report from the ...
1 cze 2023 · The Advanced Prostate Cancer Panel amended evidence- and consensus-based statements based on an updated review to aid clinicians in the management of patients with advanced prostate cancer. These statements are detailed herein.
The 2024 Advanced Prostate Cancer Consensus Conference showcases notable progress in prostate cancer management while addressing areas where high-quality evidence remains limited. Through expert consensus voting, this report offers valuable insights into contentious clinical issues of advanced prostate cancer, especially in cases where ...
12 lip 2021 · One of these new therapies is now generating promising data for men with the most aggressive prostate cancer. Radiation therapy is getting more precise, making it easier to kill tumors while sparing their surrounding tissues.
17 wrz 2024 · Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or stage 4 prostate cancer. While most advanced prostate cancer is incurable, treatments can slow or shrink the cancer, reduce symptoms and extend a person's life.
1 sty 2021 · Clinicians should discuss treatment options with advanced prostate cancer patients based on life expectancy, comorbidities, preferences, and tumor characteristics. Patient care should incorporate a multidisciplinary approach when available.
7 paź 2019 · Prostate cancer is the most common non-cutaneous malignancy in men in the Western World 1, 2. Despite substantial advances in diagnosis and treatment, prostate cancer remains a leading cause...
